RxDoctor Payments Data

Robert Milam, MD

Orthopaedic Surgery · Charlotte, NCNPI 1881676682

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Bioventus LLC at 35.5% of the total. Reporting peaked in 2020 at $10,357 and has fallen 95.8% since, to $439 in 2025.

$24,458in general payments, 2019–2025

Across 94 payments — averaging $260.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioventus LLC$9K
  • Stryker$5K
  • Medical Device Business Services, Inc.$3K
  • Cutting Edge Spine, LLC$3K
  • Globus Medical$2K
  • Orthofix Medical, Inc.$1K
  • plus $2K from 14 others
$204,890in research payments, 2019–2025

Across 47 payments — averaging $4359.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$165K
  • Globus Medical$16K
  • Bioventus LLC$15K
  • Centinel Spine, LLC$7K
  • Baxter Healthcare$2K

What the payments were for

  • Royalty or licence$2,72011%
  • Consulting fees$14,42559%
  • Speaking & faculty fees$2501%
  • Travel & lodging$3,13513%
  • Food & beverage$3,85516%
  • Education$740%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bioventus LLC5$8,679
Stryker16$5,262
Medical Device Business Services, Inc.1$2,925
Cutting Edge Spine, LLC2$2,720
Globus Medical(2 entities)17$1,815
Orthofix Medical, Inc.27$1,106
Medtronic8$507
Johnson & Johnson4$334
Synthes GmbH1$250
Cerapedics Inc.2$245
Alphatec Spine, Inc1$163
Relievant Medsystems, Inc.1$154
Intrinsic Therapeutics1$145
Medicrea USA, Corp.1$36
Heron Therapeutics, Inc.2$33
Spine Wave, Inc.1$24
Radius Health, Inc.1$19
Theragen, Inc.1$15
Zyla Life Sciences, Inc.1$13
Pfizer1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,458 in reported general payments places this provider in the 75th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina →

Medicare billing

Part B allowed, 2024
$196,143
Medicare patients
318
Services billed
925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin63$864
Celecoxib22$323
Baclofen12$267
Tizanidine Hcl68$262
Diclofenac Sodium13$195
Meloxicam62$161
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$141
Tramadol Hcl33$125
Prednisone32$113
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$97
Oxycodone Hcl15$81
Naproxen12$68
Ondansetron Hcl14$67
Cyclobenzaprine Hcl14$31

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Charlotte

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →